(Q35103477)

6 August 2017

1 reference

title

Cervical cancer and use of hormonal contraceptives: a systematic review (English)

1 reference

6 August 2017

1 reference

cervix uterine cancer

1 reference

6

Martyn Plummer

1 reference

6 August 2017

Silvia Franceschi

7

0 references

Julian Peto

series ordinal

5

object named as

Julian Peto

1 reference

6 August 2017

8

Valerie Beral

1 reference

6 August 2017

4

Paul Appleby

1 reference

Amy Berrington de González

6 August 2017

series ordinal

3

object named as

Amy Berrington de Gonzalez

1 reference

6 August 2017

Jennifer S Smith

1

1 reference

6 August 2017

Jane Green

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

6 August 2017

1 reference

6 August 2017

361

1 reference

6 August 2017

1159-1167

1 reference

6 August 2017

9364

1 reference

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Oral contraceptives, parity, and cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Long-term use of oral contraceptives and risk of invasive cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Use of oral contraceptives and risk of invasive cervical cancer in previously screened women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Oral contraceptive use and malignancies of the genital tract. Results from the Royal College of General Practitioners' Oral Contraception Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Oral contraceptives and cervical cancer risk in Costa Rica. Detection bias or causal association?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Cervical cancer risk and use of depot-medroxyprogesterone acetate in Costa Rica

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Oral contraceptive use and risk of invasive cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Injectable contraceptives and risk of invasive cervical cancer: evidence of an association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Case-control study of risk factors for cervical squamous-cell neoplasia in Denmark. III. Role of oral contraceptive use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Invasive squamous-cell cervical carcinoma and combined oral contraceptives: results from a multinational study. WHO Collaborative Study of Neoplasia and Steroid Contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Oral contraceptive use and adenocarcinoma of cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Risk factors for invasive cervix cancer in young women.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Oral contraceptives and cervical cancer--further findings from the Oxford Family Planning Association contraceptive study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Time since last use of oral contraceptives and risk of invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Smoking and oral contraceptives as risk factors for cervical carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Oral contraceptives and cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Risk factors for cervical cancer in Colombia and Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Human papillomavirus and invasive cervical cancer in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

The viral origin of cervical cancer in Rabat, Morocco

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Risk Factors for Cervical Cancer in Thailand: a Case-Control Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Causes of cervical cancer in the Philippines: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Human papillomavirus infection and invasive cervical cancer in Paraguay

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Depot-medroxyprogesterone acetate (DMPA) and risk of invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. WHO Collaborative Study of Neoplasia and Steroid Contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Cervical carcinoma in situ and use of depot-medroxyprogesterone acetate (DMPA). WHO Collaborative Study of Neoplasia and Steroid Contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Combined oral contraceptives and risk of cervical carcinoma in situ. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912949-2

7 January 2021

10.1016/S0140-6736(03)12949-2

Identifiers

DOI

1 reference

6 August 2017

1 reference